Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

428 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of Blue light photobiomodulation therapy in the treatment of chronic wounds. Results of the Blue Light for Ulcer Reduction (B.L.U.R.) Study.
Fraccalvieri M, Amadeo G, Bortolotti P, Ciliberti M, Garrubba A, Mosti G, Bianco S, Mangia A, Massa M, Hartwig V, Salvo P, Ricci EB. Fraccalvieri M, et al. Among authors: mangia a. Ital J Dermatol Venerol. 2022 Apr;157(2):187-194. doi: 10.23736/S2784-8671.21.07067-5. Epub 2021 Sep 9. Ital J Dermatol Venerol. 2022. PMID: 34498454 Free article.
Combination of dermabrasion and Apremilast for Hailey-Hailey disease.
Siliquini N, Deboli T, Marchetti Cautela J, Mangia A, Fraccalvieri M, Dapavo P, Quaglino P, Ribero S. Siliquini N, et al. Among authors: mangia a. Ital J Dermatol Venerol. 2021 Dec;156(6):727-728. doi: 10.23736/S2784-8671.20.06540-2. Epub 2020 Mar 4. Ital J Dermatol Venerol. 2021. PMID: 32129590 No abstract available.
Adherence in HCV Treatment: What We Know.
Flamm SL, Mangia A. Flamm SL, et al. Among authors: mangia a. Semin Liver Dis. 2024 Apr 24. doi: 10.1055/a-2313-0111. Online ahead of print. Semin Liver Dis. 2024. PMID: 38657680
Sofosbuvir-velpatasvir in children 3-17 years old with hepatitis C virus infection.
Jonas MM, Romero R, Rosenthal P, Lin CH, Verucchi G, Wen J, Balistreri WF, Whitworth S, Bansal S, Leung DH, Narkewicz MR, Gonzalez-Peralta RP, Mangia A, Karnsakul W, Rao GS, Shao J, de Jong J, Parhy B, Osinusi A, Kersey K, Murray KF, Sokal EM, Schwarz KB. Jonas MM, et al. Among authors: mangia a. J Pediatr Gastroenterol Nutr. 2024 Apr 21. doi: 10.1002/jpn3.12045. Online ahead of print. J Pediatr Gastroenterol Nutr. 2024. PMID: 38644678
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V; MAESTRO-NASH Investigators. Harrison SA, et al. Among authors: mangia a. N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000. N Engl J Med. 2024. PMID: 38324483 Clinical Trial.
Analysis of Patients' Characteristics and Treatment Profile of People Who Use Drugs (PWUDs) with and without a Co-Diagnosis of Viral Hepatitis C: A Real-World Retrospective Italian Analysis.
Nava FA, Mangia A, Riglietta M, Somaini L, Foschi FG, Claar E, Maida I, Ucciferri C, Frigerio F, Hernandez C, Dovizio M, Perrone V, Degli Esposti L, Puoti M. Nava FA, et al. Among authors: mangia a. Ther Clin Risk Manag. 2023 Aug 4;19:645-656. doi: 10.2147/TCRM.S409134. eCollection 2023. Ther Clin Risk Manag. 2023. PMID: 37560130 Free PMC article.
428 results